Silvercrest Asset Management Group »

Intra Cellular Therapies shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $9.9M 118k 83.52
2024-09-30 $8.7M 119k 73.17
2024-06-30 $16M 239k 68.49
2024-03-31 $2.9M 42k 69.20
2023-09-30 $4.1M 78k 52.09
2023-06-30 $5.0M 78k 63.32
2023-03-31 $3.6M 67k 54.15
2022-12-31 $5.2M 99k 52.92
2022-09-30 $4.7M 100k 46.53
2022-06-30 $5.8M 102k 57.08
2022-03-31 $6.6M 108k 61.19
2021-12-31 $5.6M 107k 52.34
2021-09-30 $6.2M 167k 37.28
2021-06-30 $6.9M 170k 40.82
2021-03-31 $5.8M 170k 33.93
2020-12-31 $6.1M 192k 31.80

Top funds holding Intra Cellular Therapies